Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Prompt Medication Adjustment and Intensive Follow-up on Achieving Lipid Targets in Patients Undergoing Carotid Endarterectomy

NCT07064135 is registered in ClinicalTrials.gov with Barmherzige Brüder Linz as lead sponsor.

NCT NCT07064135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07064135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Prompt Medication Adjustment and Intensive Follow-up on Achieving Lipid Targets in Patients Undergoing Carotid Endarterectomy
Lead sponsor
Barmherzige Brüder Linz
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 4, 2025
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carotid artery stenoses, dyslipidaemias